Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Publishes Results Demonstrating Real-World Relevance of Artificial Intelligence in Pathology

By Author Proscia | March 2, 2020

Proscia, a leading provider of artificial intelligence (AI)-enabled digital pathology software, has released the findings of a new study on the first deep learning system with proven accuracy in real laboratory environments. The study is the largest AI validation study conducted in pathology to date and supports the growing impact of AI in cancer diagnosis. The paper’s results serve as the foundation for enabling faster and more accurate diagnosis to improve treatment decisions and patient outcomes.

Our website uses cookies. By using this site, you agree to its use of cookies.